Mahmut Gümüş

机构：Istanbul Eye Hospital, Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi, Istanbul Medeniyet University · ORCID：0000-0003-3550-9993

发表论文 330 篇 · 总被引 18755 次 · h-index 38

代表论文

• Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer (2025 · New England Journal of Medicine · 被引 96)
• Health-related quality of life with belzutifan versus everolimus for advanced renal cell carcinoma (LITESPARK-005): patient-reported outcomes from a randomised, open-label, phase 3 trial (2025 · The Lancet Oncology · 被引 12)
• Trastuzumab deruxtecan (T-DXd) vs ramucirumab (RAM) + paclitaxel (PTX) in second-line treatment of patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) unresectable/metastatic gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJA): Primary analysis of the randomized, phase 3 DESTINY-Gastric04 study. (2025 · Journal of Clinical Oncology · 被引 10)
• Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50% (2025 · Cancer · 被引 8)
• Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe (2025 · Quality of Life Research · 被引 6)
• The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study (2025 · Medicina · 被引 5)